CLINICAL_TRIALS
trial_result
· 2012-12-05
Clinical Trial Update: Study of Live Attenuated ChimeriVax™-Japanese Encephalitis Vaccine [Phase 2]
Summary
Phase 2 trial of the Live Attenuated ChimeriVax-JE vaccine for Japanese encephalitis completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Japanese Encephalitis | Phase 2 | Status: COMPLETED | Results posted: 2012-12-05